Author: Neozene

Pfizer Could Release COVID Vaccine in Powder Form
November 13, 2020
By Neozene

The following article originally appeared in FiercePharma and was written by Fraiser Kansteiner Pfizer on Monday revealed stellar early results from its phase 3 COVID-19 vaccine trial, but the news was quickly met with concerns about access as the vaccine comes with hefty cold chain requirements. Pfizer, for its part, already has its sights set on a next-generation formula that could help resolve those storage concerns, the drugmaker’s top scientist said. The drugmaker is weighing several options for an improved vaccine that could be ready as early as 2021. “For the COVID-19

New Early Warning Signs of COVID Infection Identified
November 5, 2020
By Neozene

The following article originally appeared in FierceBiotech and was written by Rae Ellen Bichell, Kaiser Health News Carol Wilusz’s mornings now often start at 4 a.m., scanning the contents of undergraduates’ feces. Specifically, scanning the data on how much coronavirus they flushed into the shadows, destined to be extracted from 17 manholes connected to dorm buildings on Colorado State University’s (CSU’s) Fort Collins campus. “There are quite extensive numbers of poop jokes,” said Wilusz, a CSU molecular biologist. Emerging research suggests infected people start shedding the coronavirus in their poop early in

Scientists: The First COVID Shots May Be Less Than Optimal
October 29, 2020
By Neozene

The following article originally appeared in FiercePharma and was written by Liz Szabo, Kaiser Health News, and JoNel Aleccia, Kaiser Health News The White House and many Americans have pinned their hopes for defeating the COVID-19 pandemic on a vaccine being developed at “warp speed.” But some scientific experts warn they’re all expecting too much, too soon. “Everyone thinks COVID-19 will go away with a vaccine,” said William Haseltine, Ph.D., chair and president of Access Health International, a foundation that advocates for affordable care. Ongoing clinical trials are primarily designed to show